Skip to Content

The Choice of Immunotherapy and PARP Inhibitor for Gynecological Cancer

Charlotte Haslund, MD, chief oncologist at the Department of Oncology, Aalborg University Hospital, specializing in gynecological cancer, presented highlights and Danish perspectives on ovarian cancer at the Danish Evening at ESMO 2024.

Get access

If you are a doctor or other health professional, you can access the entire article by creating a profile on BestPractice Nordic.

Back to top